Biopsy + Biospecimen Collection + EFINEPTAKIN ALFA + PEMBROLIZUMAB

2 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Biopsy + Biospecimen Collection + EFINEPTAKIN ALFA + PEMBROLIZUMAB
Treatment and conditionWhere it standsTrials
Biopsy + Biospecimen Collection + EFINEPTAKIN ALFA + PEMBROLIZUMAB for glioblastomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Biopsy + Biospecimen Collection + EFINEPTAKIN ALFA + PEMBROLIZUMAB for gliosarcomaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1